thromboembolism disease
Conditions
Interventions
Sponsors
Affiliated Hospital of Dalian Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Patients with solid malignant tumors (confirmed by pathology/cytology); 2. After the diagnosis of malignant tumors, regular chemotherapies (including oral, intravenous and topical medications) were initiated, and the types of anti-neoplastic drugs included targeted drugs, chemotherapeutics with anti-tumor cell activity, excluding endocrine therapy, traditional Chinese medicine preparations and adjuvant drugs) were more than 1 year.
Exclusion criteria
Exclusion criteria: 1. After the diagnosis of malignant tumors, patients who had not been hospitalized for follow-up more than 6 months during regular chemotherapy; 2. After the diagnosis of malignant tumors, discontinuation of drugs occurred during intermittent chemotherapy, and the cumulative time exceeded 6 months; 3. Patients with incomplete clinical data and unable to clarify the information of cancer; 4. Patients suffer from multiple malignant tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| New onset thromboembolism disease; | — |
Countries
China
Contacts
Public ContactDaobo Li
First Affiliated Hospital of Dalian Medical University
Outcome results
None listed